Non classé
Firalis Molecular Precision acquires Olink® Explore HT panel
Firalis Molecular Precision acquires Olink® Explore HT panel, a First in France November 6, 2023 Huningue (France)...
Marketing
Non classé
MERSCOPE Grant Winner Announced
Firalis Molecular Precision announces MERSCOPE Grant Program winner Winner of the Grant Program in collaboration with Vizgen...
Non classé
BioTechX Europe
BioTechX Europe BioTechX Europe 2023, one of the biggest healthcare events in Europe, happened in Basel, Switzerland,...
Non classé
CAP Accreditation
CAP Accreditation Firalis Molecular Precision is particularly honored to have obtained accreditation from the College of American...
Non classé
BIO-Europe 2023
BIO-Europe 2023 DaysHoursMinutesSeconds Firalis Molecular Precision will be attending the upcoming BIO-Europe partnering event on November 6-8...
Non classé
August’s Newsletter is Out!
August’s Newsletter : Revolutionizing Biomarker Discovery and Clinical Testing Through Assay Development and Custom Kit Production In...
Non classé
Biomarkers and how they can be catalysts for personalized medicine
Biomarkers and how they can be catalysts for personalized medicine The concept of tailoring medical treatments to...
Non classé
July’s Newsletter is out!
July’s Newsletter is out! Exciting Times Ahead: Welcoming Our New CEO and Unveiling Our Grant Program In...
Non classé
Your Trusted Olink® Explore Panel Service Provider in France
Elevating Protein Biomarker Research with Olink® Explore Panels in France In the world of life sciences, Olink®...
Non classé
France’s Leading NGS Service Provider
France’s Leading NGS Service-Provider with Illumina’s Cutting-Edge sequencing technologies Firalis Molecular Precision has emerged as France’s leading...
